Medtech firm Bond Digital Health has employed a business growth expert to help grow its market share and expand its global reach.
Christopher Tossell has been appointed to the newly created role of Strategic Growth Director.
Chris joins Bond on the back of a 10-year career in rapid-growth healthcare technology organisations and has founded several successful businesses of his own.
He has served as a strategic growth consultant to several SME health technology companies, helping them to grow their market share.
Chris helped lead digital healthcare company The HCI Group from start-up to being featured on the Inc. 500 – an annual ranking of the fastest-growing private companies in the US – for three years in a row, including being ranked as one of the fastest growing companies in the US in 2013.
He also holds several non-executive directorships, including of Respiratory Innovation Wales.
At Bond, Chris will be part of the business’ commercial team, responsible for global business development with a particular focus on the UK and North America.
Phil Groom, Bond’s Commercial Director, said: “Chris is ambitious, entrepreneurial and driven – exactly the qualities we will need to expand our global reach.
“Even more importantly, he knows the digital healthcare market inside out, and his experience helping SME health tech companies achieve rapid growth will be invaluable as we look to grow our market share.”
Chris first met CEO Ian Bond in 2018 and has followed the company’s success story closely ever since.
He said: “For some time I’ve based my decision on which companies to partner with on two things – the who and the what: who I’m working with and what we’re looking to achieve, including the product.
“Getting a chance to work with a product as good as the Transform® platform and getting to work alongside people like Wayne Harvey, Kevin Smith, Ian Bond and the rest of the team in the next phase of Bond’s growth certainly ticked those boxes.”